Events

CBE Co-sponsored Seminar: John Kasianowicz, Ph.D., Physical Scientist, NIST, Physical Measurement Laboratory on Tues., Nov. 14th @ 2pm

Tuesday, November 14, 2017 in Elings Hall #1601 @ 2pm

 

Current Topics in Bioengineering Career Talk

Tuesday, November 14, 2017

Elings 1601

2:00 - 3:00 pm

*Light refreshments will be provided*

RSVP at: https://csep.cnsi.ucsb.edu/forms/PDS/Registration.php

John J. Kasianowicz, Ph.D.

Physical Scientist, NIST, Physical Measurement Laboratory

Visiting Professor, Columbia University, Dept. of Applied Math

 

NIST: The Final Frontier? 

NIST (the National Institute of Standards & Technology) is a non-regulatory federal research agency with campuses in Gaithersburg, MD and Boulder, CO. It focuses on research in physics, engineering, materials science, information technology and has two major collaborative centers in nanoscale science & technology and neutron research. I do basic and applied research in biophysics in the Physical Measurement laboratory, which is currently home to four outstanding Nobel prize winners. I'll describe what it's like working at NIST, what research opportunities there are for both undergraduates and newly minted PhDs, and talk about different ways scientific careers can develop (in academia, federal laboratories, and industry).

BIO: Dr. John J. Kasianowicz is the Leader of the Nanobiotechnology Project in the Physical Measurement Laboratory at NIST and a fellow of the American Physical Society. He earned a Ph.D. in Physiology & Biophysics from the State University of New York at Stony Brook, a M.A. in Physics from the State University of New York at Stony Brook, and a B.A. in Physics (with Distinction) from Boston University. John was a National Academy of Sciences/National Research Council Research Associate in the Chemical Science and Technology Laboratory at NIST prior to joining the staff and becoming a Leader of the Biomolecular Materials Group. He pioneered research in four principal areas: single molecule characterization, quantification, and identification; nanopore-based DNA sequencing; elucidating the mechanisms of bacterial toxin action, and development of new methods for membrane protein structure determination. His work led to two major efforts for nanopore-based DNA sequencing technology, which are currently valued at $1.8B. John’s current major focus area is the development of electronic systems to simultaneously quantify many biomarkers (proteins, DNA, RNA, etc.) in single cells, tissue, and blood. This research could have a marked impact on understanding basic cellular mechanisms and aid development of quantitative personalized medicine.